Prescribing information for Adtralza®▼ (tralokinumab) can be found here. Adverse Event reporting information can be found at the bottom of this page.
MAT-87096 December 2025
| Adverse events should be reported
For the United Kingdom, reporting forms and information can be found at: yellowcard.mhra.gov.uk. Adverse events should also be reported to Drug Safety at LEO Pharma by calling +44 (0)1844 347333 or e-mail [email protected] or search for MHRA Yellow Card in the Google Play or Apple App Store. |
